08.21.2018 Issue 415

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Dartmouth Probe: Welch Plagiarized Work
from Colleague, Another Researcher

Monday, August 20

Dartmouth College’s Dr. H. Gilbert Welch, a prominent health care policy expert, reportedly plagiarized material from a colleague and researcher from a separate institution, according to a STAT report.

Pharma Fights Back Against States’ Laws Aimed at Lowering Prices

PBMs Fees on Drugmakers Could Play Role in Drug Prices

Express Scripts Formulary Has Hep C, MS Exclusions

Group Says Medicare Part D Can Pull Back Rising Costs by Shifting Liability

Article: Rise of Digital Health Data Bolsters Interest in RWD

ISPOR Summit 2018 Set for Oct. 19

FDA OKs First-Ever RNA Interference Therapy

Ohio Targets PBMs After Audit Finds Spread Pricing in Medicaid


Senior Research Analyst - HEOR

Senior Director, HEOR Oncology and Specialty

Adjunct Faculty, Economics of Health Care, online

Watson Health - Lead Research Analyst (Outcomes Research)

Watson Health - Senior SAS Programmer Analyst (Medical & healthcare claims data)

Watson Health - Statistician/ Sr Statistician (HEOR/medical claims data)

Watson Health - Outcomes Researcher

Senior Principal - Health Economics

Industry Spotlight



Conferences Webinars
340B Manufacturer Summit
    August 21-22, Washington, D.C.

Bio/Pharma Forum on the State of Medicare Reform
    August 21, Arlington, Virginia

4th Annual PBM Contracting: Methodologies for Contract Innovations
    August 22-23, Chicago, Illinois

6th Annual Real-World Analytics Summit 2018
    September 1-2, Boston, Massachusetts

ESMO Academy 2018
    September 1-3, Oxford, U.K.

How to Protect Your Company’s Data Anywhere, Anytime, On Any Device
    August 22

The Next Generation PSP: How to Maximize Patient Outcomes and Boost Patient Experience Through More Advance PSP Design
    August 30

PROving Its Worth: How to Develop a PRO Strategy to Distinguish Your Product with Regulators and Payers
    September 12

Using Real World Evidence in the Real World Oncology Practice Setting
    September 19


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale


Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven